C07D 515/18
Bridged systems
C07D515/18 (Bridged systems) appears on 34 US grants and 62 published applications in this corpus.
Search patents in C07D- Granted patents
- 34
- Published applications
- 62
- Assignees
- 42
- Inventors
- 240
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 2 | 2 |
| 2012 | 3 | 3 |
| 2013 | 2 | 3 |
| 2014 | 2 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 3 |
| 2017 | 3 | 2 |
| 2018 | 2 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 2 | 5 |
| 2023 | 1 | 10 |
| 2024 | 1 | 7 |
| 2025 | 2 | 3 |
| 2026 | 4 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic compounds, compositions, and methods of using thereof9 Jun 2026US 12,649,750 B2Genzyme Corporation
- Macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them2 Jun 2026US 12,643,912 B2Les Laboratoires Servier
- Macrocyclic compounds, compositions, and methods of using thereof12 May 2026US 12,624,051 B2Genzyme Corporation
- Modulators of cystic fibrosis transmembrane conductance regulator28 Apr 2026US 12,612,416 B2Vertex Pharmaceuticals Incorporated
- Antiviral pyrazolopiridinone compounds24 Jun 2025US 12,338,220 B2Gilead Sciences, Inc.
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Novel compounds and uses thereof13 Aug 2026US 2026/0234163 A1Acelink Therapeutics, Inc.
- Compounds for treating cancer16 Jul 2026US 2026/0200943 A1Genesis Therapeutics, Inc.
- Macrocyclic heterocycles and uses thereof14 May 2026US 2026/0132133 A1Kumquat Biosciences Inc.
- Ras inhibitors19 Mar 2026US 2026/0078133 A1Revolution Medicines, Inc.
Most cited
By later US patents
- Macrocyclic integrase inhibitors13US 8,497,270 B2Elanco Animal Health Ireland Limited · 2013
- Synthesis of naturally occurring ecteinascidins and related compounds10US 7,795,260 B2Pharma Mar, S. A. · 2010
- Synthesis of naturally occurring ecteinascidins and related compounds9US 7,767,659 B2Pharma Mar, S. A. · 2010
- Conformationally constrained, fully synthetic macrocyclic compounds7US 10,017,481 B2Polyphor AG · 2018
- Inhibitors of prenyl-protein transferase7US 6,350,755 B1Merck & Co., Inc. · 2002